tiprankstipranks
Advertisement
Advertisement

CMMB Stock Latest News

Chemomab Therapeutics Sets April 28, 2026 Shareholder Meeting to Vote on Capital Increase and Governance Matters
Company AnnouncementsChemomab Therapeutics Sets April 28, 2026 Shareholder Meeting to Vote on Capital Increase and Governance Matters
20d ago
6K
CMMB
Chemomab Sets Single-Phase 3 Path With FDA After Strong 2025 Nebokitug Data
PremiumCompany Announcements
Chemomab Sets Single-Phase 3 Path With FDA After Strong 2025 Nebokitug Data
21d ago
6K
CMMB
Chemomab Therapeutics sees cash runway through 1Q27
PremiumThe Fly
Chemomab Therapeutics sees cash runway through 1Q27
21d ago
CMMB
Chemomab Therapeutics reports FY25 EPS (1c) vs. (4c) last year
PremiumThe Fly
Chemomab Therapeutics reports FY25 EPS (1c) vs. (4c) last year
21d ago
CMMB
Chemomab Therapeutics announces results of its Phase 2 SPRING trial
PremiumThe Fly
Chemomab Therapeutics announces results of its Phase 2 SPRING trial
4M ago
CMMB
Chemomab Therapeutics Advances PSC Treatment with Phase 3 Trial
PremiumCompany AnnouncementsChemomab Therapeutics Advances PSC Treatment with Phase 3 Trial
5M ago
CMMB
Chemomab Therapeutics Advances Nebokitug Phase 3 Trial with Regulatory Support
Premium
Company Announcements
Chemomab Therapeutics Advances Nebokitug Phase 3 Trial with Regulatory Support
5M ago
6K
CMMB
Chemomab Therapeutics reports Q3 EPS (0.4c) vs (1c) last year
Premium
The Fly
Chemomab Therapeutics reports Q3 EPS (0.4c) vs (1c) last year
5M ago
CMMB
Chemomab announces presentations at AASLD 2025 on nebokitug data
PremiumThe Fly
Chemomab announces presentations at AASLD 2025 on nebokitug data
5M ago
CMMB
CMMB Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CMMB Earnings this Week: How Will it Perform?
5M ago
CMMB
Chemomab Therapeutics Advances Phase 3 Plans for Nebokitug
PremiumCompany Announcements
Chemomab Therapeutics Advances Phase 3 Plans for Nebokitug
7M ago
CMMB
Chemomab Therapeutics management to meet with Maxim
PremiumThe Fly
Chemomab Therapeutics management to meet with Maxim
7M ago
CMMB
Chemomab Therapeutics price target raised to $25 from $10 at Oppenheimer
PremiumThe FlyChemomab Therapeutics price target raised to $25 from $10 at Oppenheimer
8M ago
CMMB
Chemomab Therapeutics Ltd – ADR trading halted, news pending
Premium
The Fly
Chemomab Therapeutics Ltd – ADR trading halted, news pending
8M ago
CMMB
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested
8M ago
OP
QH
Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025
PremiumCompany Announcements
Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025
8M ago
6K
CMMB
Chemomab Therapeutics: Advancing CM-101 with Strategic Financial Optimizations and FDA Support
PremiumRatings
Chemomab Therapeutics: Advancing CM-101 with Strategic Financial Optimizations and FDA Support
8M ago
CMMB
Chemomab Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Chemomab Therapeutics Reports Q2 2025 Financial Results
8M ago
6K
CMMB
Chemomab Therapeutics reports Q2 EPS 0.4c vs 0.013c last year
PremiumThe Fly
Chemomab Therapeutics reports Q2 EPS 0.4c vs 0.013c last year
8M ago
CMMB
Chemomab Therapeutics management to meet with Maxim
PremiumThe FlyChemomab Therapeutics management to meet with Maxim
8M ago
CMMB
Chemomab Therapeutics Enters Sales Agreement with LifeSci Capital
Premium
Company Announcements
Chemomab Therapeutics Enters Sales Agreement with LifeSci Capital
9M ago
6K
CMMB
Chemomab Therapeutics Announces Key Decisions from Annual Shareholders Meeting
Premium
Company Announcements
Chemomab Therapeutics Announces Key Decisions from Annual Shareholders Meeting
9M ago
6K
CMMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >